Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: August 15, 2022
Context: This filing serves to incorporate by reference a press release titled "IceCure Medical Reports Financial Results for the First Half of 2022 and Recent Operational Highlights." The filing itself does not contain the detailed financial data but directs investors to the attached press release (Exhibit 99.1) for the specific results covering the six months ended June 30, 2022.
Key Financial Metrics
The provided text is a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. It only indicates that such results and operational highlights were reported in the accompanying press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements are expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Verify the specific financial results for the first half of 2022 by reviewing the attached press release (Exhibit 99.1).
- Confirm the details of "Recent Operational Highlights" mentioned in the press release title.
- Check the Registration Statements on Form S-8 (File No. 333-262620 and File No. 333-264578) to understand how this report is incorporated by reference.
- Review subsequent filings to ensure no superseding documents have updated the information provided in this August 15, 2022 report.